{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:15:30Z","timestamp":1790511330371,"version":"4.1.0"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["No.2018SHZDZX01"],"award-info":[{"award-number":["No.2018SHZDZX01"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12035-021-02348-3","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T18:02:12Z","timestamp":1615572132000},"page":"3388-3404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Microglia Biomarkers in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"58","author":[{"given":"Peng-Fei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-0547","authenticated-orcid":false,"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"2348_CR1","doi-asserted-by":"publisher","unstructured":"2020 Alzheimer's disease facts and figures (2020). Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12068","DOI":"10.1002\/alz.12068"},{"issue":"1","key":"2348_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener 14(1):32. https:\/\/doi.org\/10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegener"},{"issue":"3","key":"2348_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ et al (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3):263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"issue":"4","key":"2348_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W et al (2018) NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement 14(4):535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"issue":"9","key":"2348_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.it.2020.07.002","volume":"41","author":"VE Miron","year":"2020","unstructured":"Miron VE, Priller J (2020) Investigating Microglia in Health and Disease: Challenges and Opportunities. Trends Immunol 41(9):785\u2013793. https:\/\/doi.org\/10.1016\/j.it.2020.07.002","journal-title":"Trends Immunol"},{"key":"2348_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.conb.2019.11.024","volume":"61","author":"C Bellenguez","year":"2020","unstructured":"Bellenguez C, Grenier-Boley B, Lambert JC (2020) Genetics of Alzheimer's disease: where we are, and where we are going. Curr Opin Neurobiol 61:40\u201348. https:\/\/doi.org\/10.1016\/j.conb.2019.11.024","journal-title":"Curr Opin Neurobiol"},{"issue":"5","key":"2348_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","volume":"26","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A et al (2020) Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nat Med 26(5):769\u2013780. https:\/\/doi.org\/10.1038\/s41591-020-0815-6","journal-title":"Nat Med"},{"issue":"2","key":"2348_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer's disease. J Cell Biol 217(2):459\u2013472. https:\/\/doi.org\/10.1083\/jcb.201709069","journal-title":"J Cell Biol"},{"key":"2348_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fnagi.2019.00233","volume":"11","author":"AL Hemonnot","year":"2019","unstructured":"Hemonnot AL, Hua J, Ulmann L, Hirbec H (2019) Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities. Front Aging Neurosci 11:233. https:\/\/doi.org\/10.3389\/fnagi.2019.00233","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"2348_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman S, Izzy S, Sen P, Morsett L, El Khoury J (2018) Microglia in neurodegeneration. Nat Neurosci 21(10):1359\u20131369. https:\/\/doi.org\/10.1038\/s41593-018-0242-x","journal-title":"Nat Neurosci"},{"issue":"1","key":"2348_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13024-018-0247-7","volume":"13","author":"L Zhong","year":"2018","unstructured":"Zhong L, Wang Z, Wang D, Wang Z, Martens YA, Wu L, Xu Y, Wang K et al (2018) Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2). Mol Neurodegener 13(1):15. https:\/\/doi.org\/10.1186\/s13024-018-0247-7","journal-title":"Mol Neurodegener"},{"issue":"4","key":"2348_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12978","volume":"18","author":"J Zhang","year":"2019","unstructured":"Zhang J, Chen B, Lu J, Wu Y, Wang S, Yao Z, Zhu L, Qiao Y et al (2019) Brains of rhesus monkeys display A\u03b2 deposits and glial pathology while lacking A\u03b2 dimers and other Alzheimer's pathologies. Aging Cell 18(4):e12978. https:\/\/doi.org\/10.1111\/acel.12978","journal-title":"Aging Cell"},{"key":"2348_CR13","doi-asserted-by":"publisher","unstructured":"Mecca C, Giambanco I, Donato R, Arcuri C (2018) Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes. Int J Mol Sci 19(1). https:\/\/doi.org\/10.3390\/ijms19010318","DOI":"10.3390\/ijms19010318"},{"issue":"3","key":"2348_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.cell.2019.05.056","volume":"178","author":"BL Heckmann","year":"2019","unstructured":"Heckmann BL, Teubner BJW, Tummers B, Boada-Romero E, Harris L, Yang M, Guy CS, Zakharenko SS et al (2019) LC3-Associated Endocytosis Facilitates \u03b2-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer's Disease. Cell 178(3):536\u2013551.e514. https:\/\/doi.org\/10.1016\/j.cell.2019.05.056","journal-title":"Cell"},{"issue":"5","key":"2348_CR15","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","volume":"97","author":"CYD Lee","year":"2018","unstructured":"Lee CYD, Daggett A, Gu X, Jiang LL, Langfelder P, Li X, Wang N, Zhao Y et al (2018) Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models. Neuron 97(5):1032\u20131048.e1035. https:\/\/doi.org\/10.1016\/j.neuron.2018.02.002","journal-title":"Neuron"},{"issue":"5","key":"2348_CR16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","volume":"97","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu X, Li X, Jiang LL, Gui X, Liu Y, Sun Y, Zhu B et al (2018) TREM2 Is a Receptor for \u03b2-Amyloid that Mediates Microglial Function. Neuron 97(5):1023\u20131031.e1027. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.031","journal-title":"Neuron"},{"issue":"3","key":"2348_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jalz.2018.09.006","volume":"15","author":"C Claes","year":"2019","unstructured":"Claes C, Van Den Daele J, Boon R, Schouteden S, Colombo A, Monasor LS, Fiers M, Ordov\u00e1s L et al (2019) Human stem cell-derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2. Alzheimers Dement 15(3):453\u2013464. https:\/\/doi.org\/10.1016\/j.jalz.2018.09.006","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2348_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M et al (2019) Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci 22(2):191\u2013204. https:\/\/doi.org\/10.1038\/s41593-018-0296-9","journal-title":"Nat Neurosci"},{"issue":"6","key":"2348_CR19","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00401-020-02138-6","volume":"139","author":"L Kleineidam","year":"2020","unstructured":"Kleineidam L, Chouraki V, Pr\u00f3chnicki T, van der Lee SJ, Madrid-M\u00e1rquez L, Wagner-Thelen H, Karaca I, Weinhold L et al (2020) PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol 139(6):1025\u20131044. https:\/\/doi.org\/10.1007\/s00401-020-02138-6","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2348_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O'Loughlin E et al (2017) The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity 47(3):566\u2013581.e569. https:\/\/doi.org\/10.1016\/j.immuni.2017.08.008","journal-title":"Immunity"},{"issue":"3","key":"2348_CR21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.celrep.2019.09.013","volume":"29","author":"A Carrillo-Jimenez","year":"2019","unstructured":"Carrillo-Jimenez A, Deniz \u00d6, Niklison-Chirou MV, Ruiz R, Bezerra-Salom\u00e3o K, Stratoulias V, Amouroux R, Yip PK et al (2019) TET2 Regulates the Neuroinflammatory Response in Microglia. Cell Rep 29(3):697\u2013713.e698. https:\/\/doi.org\/10.1016\/j.celrep.2019.09.013","journal-title":"Cell Rep"},{"issue":"2","key":"2348_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.celrep.2019.08.104","volume":"29","author":"YC Hsieh","year":"2019","unstructured":"Hsieh YC, Guo C, Yalamanchili HK, Abreha M, Al-Ouran R, Li Y, Dammer EB, Lah JJ et al (2019) Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer's Disease. Cell Rep 29(2):301\u2013316.e310. https:\/\/doi.org\/10.1016\/j.celrep.2019.08.104","journal-title":"Cell Rep"},{"issue":"5","key":"2348_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","volume":"99","author":"B Eftekharzadeh","year":"2018","unstructured":"Eftekharzadeh B, Daigle JG, Kapinos LE, Coyne A, Schiantarelli J, Carlomagno Y, Cook C, Miller SJ et al (2018) Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron 99(5):925\u2013940.e927. https:\/\/doi.org\/10.1016\/j.neuron.2018.07.039","journal-title":"Neuron"},{"issue":"8","key":"2348_CR24","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41591-020-0938-9","volume":"26","author":"S Dujardin","year":"2020","unstructured":"Dujardin S, Commins C, Lathuiliere A, Beerepoot P, Fernandes AR, Kamath TV, De Los Santos MB, Klickstein N et al (2020) Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease. Nat Med 26(8):1256\u20131263. https:\/\/doi.org\/10.1038\/s41591-020-0938-9","journal-title":"Nat Med"},{"issue":"1","key":"2348_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13024-018-0296-y","volume":"13","author":"H Wang","year":"2018","unstructured":"Wang H, Li Y, Ryder JW, Hole JT, Ebert PJ, Airey DC, Qian HR, Logsdon B et al (2018) Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model. Mol Neurodegener 13(1):65. https:\/\/doi.org\/10.1186\/s13024-018-0296-y","journal-title":"Mol Neurodegener"},{"issue":"8","key":"2348_CR26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns CEG, Gratuze M, Narasimhan S, Jain N, Koscal LJ, Jiang H, Manis M, Colonna M et al (2019) TREM2 function impedes tau seeding in neuritic plaques. Nat Neurosci 22(8):1217\u20131222. https:\/\/doi.org\/10.1038\/s41593-019-0433-0","journal-title":"Nat Neurosci"},{"issue":"4","key":"2348_CR27","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, Luo W, Colonna M et al (2016) TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron 90(4):724\u2013739. https:\/\/doi.org\/10.1016\/j.neuron.2016.05.003","journal-title":"Neuron"},{"issue":"40","key":"2348_CR28","doi-asserted-by":"publisher","first-page":"10172","DOI":"10.1073\/pnas.1811411115","volume":"115","author":"FA Sayed","year":"2018","unstructured":"Sayed FA, Telpoukhovskaia M, Kodama L, Li Y, Zhou Y, Le D, Hauduc A, Ludwig C et al (2018) Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy. Proc Natl Acad Sci U S A 115(40):10172\u201310177. https:\/\/doi.org\/10.1073\/pnas.1811411115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"43","key":"2348_CR29","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"CEG Leyns","year":"2017","unstructured":"Leyns CEG, Ulrich JD, Finn MB, Stewart FR, Koscal LJ, Remolina Serrano J, Robinson GO, Anderson E et al (2017) TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc Natl Acad Sci U S A 114(43):11524\u201311529. https:\/\/doi.org\/10.1073\/pnas.1710311114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2348_CR30","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1172\/jci138179","volume":"130","author":"M Gratuze","year":"2020","unstructured":"Gratuze M, Leyns CE, Sauerbeck AD, St-Pierre MK, Xiong M, Kim N, Serrano JR, Tremblay M et al (2020) Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration. J Clin Invest 130(9):4954\u20134968. https:\/\/doi.org\/10.1172\/jci138179","journal-title":"J Clin Invest"},{"issue":"7784","key":"2348_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S et al (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575(7784):669\u2013673. https:\/\/doi.org\/10.1038\/s41586-019-1769-z","journal-title":"Nature"},{"issue":"2","key":"2348_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00281-016-0581-1","volume":"39","author":"FM Marim","year":"2017","unstructured":"Marim FM, Franco MMC, Gomes MTR, Miraglia MC, Giambartolomei GH, Oliveira SC (2017) The role of NLRP3 and AIM2 in inflammasome activation during Brucella abortus infection. Semin Immunopathol 39(2):215\u2013223. https:\/\/doi.org\/10.1007\/s00281-016-0581-1","journal-title":"Semin Immunopathol"},{"issue":"4","key":"2348_CR33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"IC Stancu","year":"2019","unstructured":"Stancu IC, Cremers N, Vanrusselt H, Couturier J, Vanoosthuyse A, Kessels S, Lodder C, Br\u00f4ne B et al (2019) Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol 137(4):599\u2013617. https:\/\/doi.org\/10.1007\/s00401-018-01957-y","journal-title":"Acta Neuropathol"},{"issue":"11","key":"2348_CR34","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi Y, Manis M, Long J, Wang K, Sullivan PM, Remolina Serrano J, Hoyle R, Holtzman DM (2019) Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med 216(11):2546\u20132561. https:\/\/doi.org\/10.1084\/jem.20190980","journal-title":"J Exp Med"},{"issue":"6","key":"2348_CR35","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic B, Huntley MA, De Mazi\u00e8re A, Meilandt WJ, Wu T, Srinivasan K, Jiang Z, Gandham V et al (2018) Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies. Neuron 100(6):1322\u20131336.e1327. https:\/\/doi.org\/10.1016\/j.neuron.2018.10.014","journal-title":"Neuron"},{"issue":"1","key":"2348_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13024-020-0357-x","volume":"15","author":"F El Gaamouch","year":"2020","unstructured":"El Gaamouch F, Audrain M, Lin WJ, Beckmann N, Jiang C, Hariharan S, Heeger PS, Schadt EE et al (2020) VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice. Mol Neurodegener 15(1):4. https:\/\/doi.org\/10.1186\/s13024-020-0357-x","journal-title":"Mol Neurodegener"},{"issue":"11","key":"2348_CR37","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1093\/brain\/awz288","volume":"142","author":"K Carvalho","year":"2019","unstructured":"Carvalho K, Faivre E, Pietrowski MJ, Marques X, Gomez-Murcia V, Deleau A, Huin V, Hansen JN et al (2019) Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor. Brain 142(11):3636\u20133654. https:\/\/doi.org\/10.1093\/brain\/awz288","journal-title":"Brain"},{"key":"2348_CR38","doi-asserted-by":"publisher","unstructured":"Houtman J, Freitag K, Gimber N, Schmoranzer J, Heppner FL, Jendrach M (2019) Beclin1-driven autophagy modulates the inflammatory response of microglia via NLRP3. Embo J 38(4). https:\/\/doi.org\/10.15252\/embj.201899430","DOI":"10.15252\/embj.201899430"},{"issue":"11","key":"2348_CR39","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1016\/j.celrep.2020.02.025","volume":"30","author":"LL Friker","year":"2020","unstructured":"Friker LL, Scheiblich H, Hochheiser IV, Brinkschulte R, Riedel D, Latz E, Geyer M, Heneka MT (2020) \u03b2-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia. Cell Rep 30(11):3743\u20133754.e3746. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.025","journal-title":"Cell Rep"},{"issue":"15","key":"2348_CR40","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.7150\/thno.26164","volume":"8","author":"M Zhang","year":"2018","unstructured":"Zhang M, Qian C, Zheng ZG, Qian F, Wang Y, Thu PM, Zhang X, Zhou Y et al (2018) Jujuboside A promotes A\u03b2 clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl\/HSP90\/PPAR\u03b3 pathway. Theranostics 8(15):4262\u20134278. https:\/\/doi.org\/10.7150\/thno.26164","journal-title":"Theranostics"},{"issue":"5","key":"2348_CR41","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, Llapashtica C, Wang J et al (2020) TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge. Neuron 105(5):837\u2013854.e839. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.007","journal-title":"Neuron"},{"issue":"1","key":"2348_CR42","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41467-017-00523-6","volume":"8","author":"Z Niu","year":"2017","unstructured":"Niu Z, Shi Q, Zhang W, Shu Y, Yang N, Chen B, Wang Q, Zhao X et al (2017) Caspase-1 cleaves PPAR\u03b3 for potentiating the pro-tumor action of TAMs. Nat Commun 8(1):766. https:\/\/doi.org\/10.1038\/s41467-017-00523-6","journal-title":"Nat Commun"},{"issue":"8","key":"2348_CR43","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/oby.2008.269","volume":"16","author":"F He","year":"2008","unstructured":"He F, Doucet JA, Stephens JM (2008) Caspase-mediated degradation of PPARgamma proteins in adipocytes. Obesity (Silver Spring) 16(8):1735\u20131741. https:\/\/doi.org\/10.1038\/oby.2008.269","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"2348_CR44","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","volume":"136","author":"JL Molinuevo","year":"2018","unstructured":"Molinuevo JL, Ayton S, Batrla R, Bednar MM, Bittner T, Cummings J, Fagan AM, Hampel H et al (2018) Current state of Alzheimer's fluid biomarkers. Acta Neuropathol 136(6):821\u2013853. https:\/\/doi.org\/10.1007\/s00401-018-1932-x","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2348_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jalz.2014.02.004","volume":"11","author":"K Blennow","year":"2015","unstructured":"Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H (2015) Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimers Dement 11(1):58\u201369. https:\/\/doi.org\/10.1016\/j.jalz.2014.02.004","journal-title":"Alzheimers Dement"},{"key":"2348_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneuroim.2018.03.003","volume":"319","author":"LM Bekris","year":"2018","unstructured":"Bekris LM, Khrestian M, Dyne E, Shao Y, Pillai JA, Rao SM, Bemiller SM, Lamb B et al (2018) Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease. J Neuroimmunol 319:19\u201327. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.03.003","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2348_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"M Su\u00e1rez-Calvet","year":"2019","unstructured":"Su\u00e1rez-Calvet M, Morenas-Rodr\u00edguez E, Kleinberger G, Schlepckow K, Araque Caballero M, Franzmeier N, Capell A, Fellerer K et al (2019) Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology. Mol Neurodegener 14(1):1. https:\/\/doi.org\/10.1186\/s13024-018-0301-5","journal-title":"Mol Neurodegener"},{"key":"2348_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","volume":"11","author":"A Heslegrave","year":"2016","unstructured":"Heslegrave A, Heywood W, Paterson R, Magdalinou N, Svensson J, Johansson P, \u00d6hrfelt A, Blennow K et al (2016) Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease. Mol Neurodegener 11:3. https:\/\/doi.org\/10.1186\/s13024-016-0071-x","journal-title":"Mol Neurodegener"},{"key":"2348_CR49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neurobiolaging.2018.10.022","volume":"74","author":"BS Rauchmann","year":"2019","unstructured":"Rauchmann BS, Schneider-Axmann T, Alexopoulos P, Perneczky R (2019) CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum. Neurobiol Aging 74:182\u2013190. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.10.022","journal-title":"Neurobiol Aging"},{"key":"2348_CR50","doi-asserted-by":"publisher","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, Piccio L, Cruchaga C et al (2019) Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease. Sci Transl Med 11(507). https:\/\/doi.org\/10.1126\/scitranslmed.aav6221","DOI":"10.1126\/scitranslmed.aav6221"},{"issue":"1","key":"2348_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12974-019-1399-2","volume":"16","author":"K Nordengen","year":"2019","unstructured":"Nordengen K, Kirsebom BE, Henjum K, Selnes P, G\u00edslad\u00f3ttir B, Wettergreen M, Torsetnes SB, Gr\u00f8ntvedt GR et al (2019) Glial activation and inflammation along the Alzheimer's disease continuum. J Neuroinflammation 16(1):46. https:\/\/doi.org\/10.1186\/s12974-019-1399-2","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2348_CR52","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12974-018-1331-1","volume":"15","author":"K Henjum","year":"2018","unstructured":"Henjum K, Quist-Paulsen E, Zetterberg H, Blennow K, Nilsson LNG, Watne LO (2018) CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers A\u03b242, t-tau and p-tau. J Neuroinflammation 15(1):304. https:\/\/doi.org\/10.1186\/s12974-018-1331-1","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2348_CR53","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13195-018-0405-8","volume":"10","author":"IOC Woollacott","year":"2018","unstructured":"Woollacott IOC, Nicholas JM, Heslegrave A, Heller C, Foiani MS, Dick KM, Russell LL, Paterson RW et al (2018) Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup. Alzheimers Res Ther 10(1):79. https:\/\/doi.org\/10.1186\/s13195-018-0405-8","journal-title":"Alzheimers Res Ther"},{"key":"2348_CR54","doi-asserted-by":"publisher","first-page":"241.e213","DOI":"10.1016\/j.neurobiolaging.2019.05.008","volume":"84","author":"XH Hou","year":"2019","unstructured":"Hou XH, Bi YL, Tan MS, Xu W, Li JQ, Shen XN, Dou KX, Tan CC et al (2019) Genome-wide association study identifies Alzheimer's risk variant in MS4A6A influencing cerebrospinal fluid sTREM2 levels. Neurobiol Aging 84:241.e213\u2013241.e220. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.05.008","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2348_CR55","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/cercor\/bhz240","volume":"30","author":"NB Halaas","year":"2020","unstructured":"Halaas NB, Henjum K, Blennow K, Dakhil S, Idland AV, Nilsson LN, Sederevicius D, Vidal-Pi\u00f1eiro D et al (2020) CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults. Cereb Cortex 30(4):2295\u20132306. https:\/\/doi.org\/10.1093\/cercor\/bhz240","journal-title":"Cereb Cortex"},{"key":"2348_CR56","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fnins.2018.00609","volume":"12","author":"JR Perea","year":"2018","unstructured":"Perea JR, Lle\u00f3 A, Alcolea D, Fortea J, \u00c1vila J, Bol\u00f3s M (2018) Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer's Disease. Front Neurosci 12:609. https:\/\/doi.org\/10.3389\/fnins.2018.00609","journal-title":"Front Neurosci"},{"key":"2348_CR57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2019.10.012","volume":"86","author":"A Li","year":"2020","unstructured":"Li A, Zhao J, Fan C, Zhu L, Huang C, Li Q, Gan D, Wen C et al (2020) Delivery of exogenous proteins by mesenchymal stem cells attenuates early memory deficits in a murine model of Alzheimer's disease. Neurobiol Aging 86:81\u201391. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.10.012","journal-title":"Neurobiol Aging"},{"issue":"5","key":"2348_CR58","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1523\/jneurosci.1333-19.2019","volume":"40","author":"Q Fan","year":"2020","unstructured":"Fan Q, He W, Gayen M, Benoit MR, Luo X, Hu X, Yan R (2020) Activated CX3CL1\/Smad2 Signals Prevent Neuronal Loss and Alzheimer's Tau Pathology-Mediated Cognitive Dysfunction. J Neurosci 40(5):1133\u20131144. https:\/\/doi.org\/10.1523\/jneurosci.1333-19.2019","journal-title":"J Neurosci"},{"issue":"8","key":"2348_CR59","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2174\/1567205017666201109095657","volume":"17","author":"A Kulczy\u0144ska-Przybik","year":"2020","unstructured":"Kulczy\u0144ska-Przybik A, S\u0142owik A, Mroczko P, Borawski B, Groblewska M, Borawska R, Mroczko B (2020) Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia. Curr Alzheimer Res 17(8):709\u2013721. https:\/\/doi.org\/10.2174\/1567205017666201109095657","journal-title":"Curr Alzheimer Res"},{"key":"2348_CR60","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fnagi.2017.00210","volume":"9","author":"C Lauridsen","year":"2017","unstructured":"Lauridsen C, Sando SB, M\u00f8ller I, Berge G, Pomary PK, Gr\u00f8ntvedt GR, Salvesen \u00d8, Br\u00e5then G et al (2017) Cerebrospinal Fluid A\u03b243 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer's Disease, But Has Similar Diagnostic Accuracy to A\u03b242. Front Aging Neurosci 9:210. https:\/\/doi.org\/10.3389\/fnagi.2017.00210","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2348_CR61","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3233\/jad-150069","volume":"46","author":"P K\u00f6rtv\u00e9lyessy","year":"2015","unstructured":"K\u00f6rtv\u00e9lyessy P, Gukasjan A, Sweeney-Reed CM, Heinze HJ, Thurner L, Bittner DM (2015) Progranulin and Amyloid-\u03b2 Levels: Relationship to Neuropsychology in Frontotemporal and Alzheimer's Disease. J Alzheimers Dis 46(2):375\u2013380. https:\/\/doi.org\/10.3233\/jad-150069","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2348_CR62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s40478-019-0862-8","volume":"7","author":"A Mendsaikhan","year":"2019","unstructured":"Mendsaikhan A, Tooyama I, Bellier JP, Serrano GE, Sue LI, Lue LF, Beach TG, Walker DG (2019) Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology. Acta Neuropathol Commun 7(1):215. https:\/\/doi.org\/10.1186\/s40478-019-0862-8","journal-title":"Acta Neuropathol Commun"},{"key":"2348_CR63","doi-asserted-by":"publisher","unstructured":"Su\u00e1rez-Calvet M, Capell A, Araque Caballero M, Morenas-Rodr\u00edguez E, Fellerer K, Franzmeier N, Kleinberger G, Eren E, Deming Y, Piccio L, Karch CM, Cruchaga C, Paumier K, Bateman RJ, Fagan AM, Morris JC, Levin J, Danek A, Jucker M, Masters CL, Rossor MN, Ringman JM, Shaw LM, Trojanowski JQ, Weiner M, Ewers M, Haass C (2018) CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. EMBO Mol Med 10(12). https:\/\/doi.org\/10.15252\/emmm.201809712","DOI":"10.15252\/emmm.201809712"},{"issue":"1","key":"2348_CR64","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.1038\/s41598-019-44173-8","volume":"9","author":"E Morenas-Rodr\u00edguez","year":"2019","unstructured":"Morenas-Rodr\u00edguez E, Alcolea D, Su\u00e1rez-Calvet M, Mu\u00f1oz-Llahuna L, Vilaplana E, Sala I, Subirana A, Querol-Vilaseca M et al (2019) Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease. Sci Rep 9(1):7803. https:\/\/doi.org\/10.1038\/s41598-019-44173-8","journal-title":"Sci Rep"},{"key":"2348_CR65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2019.12.012","volume":"88","author":"L Batzu","year":"2020","unstructured":"Batzu L, Westman E, Pereira JB (2020) Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease. Neurobiol Aging 88:61\u201370. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.12.012","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2348_CR66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40478-018-0612-3","volume":"6","author":"M H\u00fcttenrauch","year":"2018","unstructured":"H\u00fcttenrauch M, Ogorek I, Klafki H, Otto M, Stadelmann C, Weggen S, Wiltfang J, Wirths O (2018) Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia. Acta Neuropathol Commun 6(1):108. https:\/\/doi.org\/10.1186\/s40478-018-0612-3","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"2348_CR67","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.bbadis.2016.07.007","volume":"1862","author":"W Kamphuis","year":"2016","unstructured":"Kamphuis W, Kooijman L, Schetters S, Orre M, Hol EM (2016) Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease. Biochim Biophys Acta 1862(10):1847\u20131860. https:\/\/doi.org\/10.1016\/j.bbadis.2016.07.007","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2348_CR68","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13195-019-0545-5","volume":"11","author":"NJ Ashton","year":"2019","unstructured":"Ashton NJ, Su\u00e1rez-Calvet M, Heslegrave A, Hye A, Razquin C, Pastor P, Sanchez-Valle R, Molinuevo JL et al (2019) Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers. Alzheimers Res Ther 11(1):94. https:\/\/doi.org\/10.1186\/s13195-019-0545-5","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2348_CR69","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.diabet.2017.06.006","volume":"45","author":"M Tanaka","year":"2019","unstructured":"Tanaka M, Yamakage H, Masuda S, Inoue T, Ohue-Kitano R, Araki R, Matoba Y, Saito M et al (2019) Serum soluble TREM2 is a potential novel biomarker of cognitive impairment in Japanese non-obese patients with diabetes. Diabetes Metab 45(1):86\u201389. https:\/\/doi.org\/10.1016\/j.diabet.2017.06.006","journal-title":"Diabetes Metab"},{"issue":"1","key":"2348_CR70","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ana.25385","volume":"85","author":"T Ohara","year":"2019","unstructured":"Ohara T, Hata J, Tanaka M, Honda T, Yamakage H, Yoshida D, Inoue T, Hirakawa Y et al (2019) Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study. Ann Neurol 85(1):47\u201358. https:\/\/doi.org\/10.1002\/ana.25385","journal-title":"Ann Neurol"},{"issue":"7","key":"2348_CR71","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1080\/00207454.2019.1702548","volume":"130","author":"Q Wang","year":"2020","unstructured":"Wang Q, Xu Y, Qi C, Liu A, Zhao Y (2020) Association study of serum soluble TREM2 with vascular dementia in Chinese Han population. Int J Neurosci 130(7):708\u2013712. https:\/\/doi.org\/10.1080\/00207454.2019.1702548","journal-title":"Int J Neurosci"},{"issue":"2","key":"2348_CR72","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neulet.2008.03.019","volume":"436","author":"TS Kim","year":"2008","unstructured":"Kim TS, Lim HK, Lee JY, Kim DJ, Park S, Lee C, Lee CU (2008) Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 436(2):196\u2013200. https:\/\/doi.org\/10.1016\/j.neulet.2008.03.019","journal-title":"Neurosci Lett"},{"issue":"11","key":"2348_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0326-z","volume":"51","author":"DK Kim","year":"2019","unstructured":"Kim DK, Han D, Park J, Choi H, Park JC, Cha MY, Woo J, Byun MS et al (2019) Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease. Exp Mol Med 51(11):1\u201317. https:\/\/doi.org\/10.1038\/s12276-019-0326-z","journal-title":"Exp Mol Med"},{"issue":"1","key":"2348_CR74","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13195-020-00619-0","volume":"12","author":"G Tondo","year":"2020","unstructured":"Tondo G, Iaccarino L, Caminiti SP, Presotto L, Santangelo R, Iannaccone S, Magnani G, Perani D (2020) The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease. Alzheimers Res Ther 12(1):50. https:\/\/doi.org\/10.1186\/s13195-020-00619-0","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"2348_CR75","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/brain\/aww349","volume":"140","author":"Z Fan","year":"2017","unstructured":"Fan Z, Brooks DJ, Okello A, Edison P (2017) An early and late peak in microglial activation in Alzheimer's disease trajectory. Brain 140(3):792\u2013803. https:\/\/doi.org\/10.1093\/brain\/aww349","journal-title":"Brain"},{"issue":"1","key":"2348_CR76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12974-020-01820-6","volume":"17","author":"R Ismail","year":"2020","unstructured":"Ismail R, Parbo P, Madsen LS, Hansen AK, Hansen KV, Schaldemose JL, Kjeldsen PL, Stokholm MG et al (2020) The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study. J Neuroinflammation 17(1):151. https:\/\/doi.org\/10.1186\/s12974-020-01820-6","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2348_CR77","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13195-019-0574-0","volume":"12","author":"P Parbo","year":"2020","unstructured":"Parbo P, Madsen LS, Ismail R, Zetterberg H, Blennow K, Eskildsen SF, Vorup-Jensen T, Brooks DJ (2020) Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease. Alzheimers Res Ther 12(1):3. https:\/\/doi.org\/10.1186\/s13195-019-0574-0","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"2348_CR78","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1093\/brain\/awy188","volume":"141","author":"M Dani","year":"2018","unstructured":"Dani M, Wood M, Mizoguchi R, Fan Z, Walker Z, Morgan R, Hinz R, Biju M et al (2018) Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease. Brain 141(9):2740\u20132754. https:\/\/doi.org\/10.1093\/brain\/awy188","journal-title":"Brain"},{"key":"2348_CR79","doi-asserted-by":"publisher","unstructured":"Cisbani G, Koppel A, Knezevic D, Suridjan I, Mizrahi R, Bazinet RP (2020) Peripheral cytokine and fatty acid associations with neuroinflammation in AD and aMCI patients: An exploratory study. Brain Behav Immun. https:\/\/doi.org\/10.1016\/j.bbi.2020.02.014","DOI":"10.1016\/j.bbi.2020.02.014"},{"key":"2348_CR80","doi-asserted-by":"publisher","unstructured":"Sacher C, Blume T, Beyer L, Biechele G, Sauerbeck J, Eckenweber F, Deussing M, Focke C et al (2020) Asymmetry of fibrillar plaque burden in amyloid mouse models. J Nucl Med. https:\/\/doi.org\/10.2967\/jnumed.120.242750","DOI":"10.2967\/jnumed.120.242750"},{"issue":"1","key":"2348_CR81","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12974-018-1347-6","volume":"15","author":"T Blume","year":"2018","unstructured":"Blume T, Focke C, Peters F, Deussing M, Albert NL, Lindner S, Gildehaus FJ, von Ungern-Sternberg B et al (2018) Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo \u03bcPET-study. J Neuroinflammation 15(1):307. https:\/\/doi.org\/10.1186\/s12974-018-1347-6","journal-title":"J Neuroinflammation"},{"issue":"9","key":"2348_CR82","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1007\/s00415-019-09400-2","volume":"266","author":"T Terada","year":"2019","unstructured":"Terada T, Yokokura M, Obi T, Bunai T, Yoshikawa E, Ando I, Shimada H, Suhara T et al (2019) In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease. J Neurol 266(9):2186\u20132196. https:\/\/doi.org\/10.1007\/s00415-019-09400-2","journal-title":"J Neurol"},{"issue":"1","key":"2348_CR83","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12974-019-1604-3","volume":"16","author":"S Yamagishi","year":"2019","unstructured":"Yamagishi S, Iga Y, Nakamura M, Takizawa C, Fukumoto D, Kakiuchi T, Nishiyama S, Ohba H et al (2019) Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study. J Neuroinflammation 16(1):208. https:\/\/doi.org\/10.1186\/s12974-019-1604-3","journal-title":"J Neuroinflammation"},{"issue":"12","key":"2348_CR84","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s00259-016-3457-7","volume":"43","author":"R Ahmad","year":"2016","unstructured":"Ahmad R, Postnov A, Bormans G, Versijpt J, Vandenbulcke M, Van Laere K (2016) Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease. Eur J Nucl Med Mol Imaging 43(12):2219\u20132227. https:\/\/doi.org\/10.1007\/s00259-016-3457-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"2348_CR85","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.1007\/s12035-017-0676-2","volume":"55","author":"L Wang","year":"2018","unstructured":"Wang L, Liu BJ, Cao Y, Xu WQ, Sun DS, Li MZ, Shi FX, Li M et al (2018) Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK\/GSK3\u03b2 Pathway. Mol Neurobiol 55(6):4731\u20134744. https:\/\/doi.org\/10.1007\/s12035-017-0676-2","journal-title":"Mol Neurobiol"},{"issue":"3","key":"2348_CR86","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3233\/jad-180142","volume":"64","author":"L Wang","year":"2018","unstructured":"Wang L, Shi FX, Xu WQ, Cao Y, Li N, Li M, Wang Q, Wang JZ et al (2018) The Down-Expression of ACE and IDE Exacerbates Exogenous Amyloid-\u03b2 Neurotoxicity in CB2R-\/- Mice. J Alzheimers Dis 64(3):957\u2013971. https:\/\/doi.org\/10.3233\/jad-180142","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2348_CR87","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3233\/jad-180230","volume":"64","author":"AC Schm\u00f6le","year":"2018","unstructured":"Schm\u00f6le AC, Lundt R, Toporowski G, Hansen JN, Beins E, Halle A, Zimmer A (2018) Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology. J Alzheimers Dis 64(2):379\u2013392. https:\/\/doi.org\/10.3233\/jad-180230","journal-title":"J Alzheimers Dis"},{"key":"2348_CR88","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3389\/fnagi.2017.00244","volume":"9","author":"DG Walker","year":"2017","unstructured":"Walker DG, Tang TM, Lue LF (2017) Studies on Colony Stimulating Factor Receptor-1 and Ligands Colony Stimulating Factor-1 and Interleukin-34 in Alzheimer's Disease Brains and Human Microglia. Front Aging Neurosci 9:244. https:\/\/doi.org\/10.3389\/fnagi.2017.00244","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"2348_CR89","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1073\/pnas.1812155116","volume":"116","author":"AG Horti","year":"2019","unstructured":"Horti AG, Naik R, Foss CA, Minn I, Misheneva V, Du Y, Wang Y, Mathews WB et al (2019) PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R). Proc Natl Acad Sci U S A 116(5):1686\u20131691. https:\/\/doi.org\/10.1073\/pnas.1812155116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2348_CR90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna J, Philipp S, Albay R 3rd, Reyes-Ruiz JM, Baglietto-Vargas D, LaFerla FM, Glabe CG (2018) Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease. Mol Neurodegener 13(1):11. https:\/\/doi.org\/10.1186\/s13024-018-0244-x","journal-title":"Mol Neurodegener"},{"issue":"1","key":"2348_CR91","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1038\/s41467-019-11674-z","volume":"10","author":"E Spangenberg","year":"2019","unstructured":"Spangenberg E, Severson PL, Hohsfield LA, Crapser J, Zhang J, Burton EA, Zhang Y, Spevak W et al (2019) Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model. Nat Commun 10(1):3758. https:\/\/doi.org\/10.1038\/s41467-019-11674-z","journal-title":"Nat Commun"},{"issue":"10","key":"2348_CR92","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/brain\/awz241","volume":"142","author":"R Mancuso","year":"2019","unstructured":"Mancuso R, Fryatt G, Cleal M, Obst J, Pipi E, Monz\u00f3n-Sandoval J, Ribe E, Winchester L et al (2019) CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain 142(10):3243\u20133264. https:\/\/doi.org\/10.1093\/brain\/awz241","journal-title":"Brain"},{"key":"2348_CR93","doi-asserted-by":"publisher","unstructured":"Walker DG, Tang TM, Mendsaikhan A, Tooyama I, Serrano GE, Sue LI, Beach TG, Lue LF (2020) Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains. Int J Mol Sci 21(2). https:\/\/doi.org\/10.3390\/ijms21020678","DOI":"10.3390\/ijms21020678"},{"issue":"1","key":"2348_CR94","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s40478-019-0828-x","volume":"7","author":"DK Franco-Bocanegra","year":"2019","unstructured":"Franco-Bocanegra DK, George B, Lau LC, Holmes C, Nicoll JAR, Boche D (2019) Microglial motility in Alzheimer's disease and after A\u03b242 immunotherapy: a human post-mortem study. Acta Neuropathol Commun 7(1):174. https:\/\/doi.org\/10.1186\/s40478-019-0828-x","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"2348_CR95","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/glia.23097","volume":"65","author":"A Mildner","year":"2017","unstructured":"Mildner A, Huang H, Radke J, Stenzel W, Priller J (2017) P2Y(12) receptor is expressed on human microglia under physiological conditions throughout development and is sensitive to neuroinflammatory diseases. Glia 65(2):375\u2013387. https:\/\/doi.org\/10.1002\/glia.23097","journal-title":"Glia"},{"issue":"3","key":"2348_CR96","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1039\/c8mt00004b","volume":"10","author":"DG Peters","year":"2018","unstructured":"Peters DG, Pollack AN, Cheng KC, Sun D, Saido T, Haaf MP, Yang QX, Connor JR et al (2018) Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice. Metallomics 10(3):426\u2013443. https:\/\/doi.org\/10.1039\/c8mt00004b","journal-title":"Metallomics"},{"issue":"9","key":"2348_CR97","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/j.neurobiolaging.2015.05.022","volume":"36","author":"MM Zeineh","year":"2015","unstructured":"Zeineh MM, Chen Y, Kitzler HH, Hammond R, Vogel H, Rutt BK (2015) Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease. Neurobiol Aging 36(9):2483\u20132500. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.05.022","journal-title":"Neurobiol Aging"},{"key":"2348_CR98","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neurobiolaging.2017.10.017","volume":"62","author":"M Bulk","year":"2018","unstructured":"Bulk M, Abdelmoula WM, Nabuurs RJA, van der Graaf LM, Mulders CWH, Mulder AA, Jost CR, Koster AJ et al (2018) Postmortem MRI and histology demonstrate differential iron accumulation and cortical myelin organization in early- and late-onset Alzheimer's disease. Neurobiol Aging 62:231\u2013242. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.10.017","journal-title":"Neurobiol Aging"},{"issue":"4","key":"2348_CR99","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3233\/jad-161143","volume":"60","author":"S van Duijn","year":"2017","unstructured":"van Duijn S, Bulk M, van Duinen SG, Nabuurs RJA, van Buchem MA, van der Weerd L, Natt\u00e9 R (2017) Cortical Iron Reflects Severity of Alzheimer's Disease. J Alzheimers Dis 60(4):1533\u20131545. https:\/\/doi.org\/10.3233\/jad-161143","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"2348_CR100","doi-asserted-by":"publisher","first-page":"e1331","DOI":"10.1212\/wnl.0000000000007133","volume":"92","author":"GD Femminella","year":"2019","unstructured":"Femminella GD, Dani M, Wood M, Fan Z, Calsolaro V, Atkinson R, Edginton T, Hinz R et al (2019) Microglial activation in early Alzheimer trajectory is associated with higher gray matter volume. Neurology 92(12):e1331\u2013e1343. https:\/\/doi.org\/10.1212\/wnl.0000000000007133","journal-title":"Neurology"},{"issue":"4","key":"2348_CR101","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3233\/jad-150827","volume":"51","author":"GD Femminella","year":"2016","unstructured":"Femminella GD, Ninan S, Atkinson R, Fan Z, Brooks DJ, Edison P (2016) Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia? J Alzheimers Dis 51(4):1275\u20131289. https:\/\/doi.org\/10.3233\/jad-150827","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"2348_CR102","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1523\/jneurosci.1184-19.2019","volume":"40","author":"TW Schmitz","year":"2020","unstructured":"Schmitz TW, Soreq H, Poirier J, Spreng RN (2020) Longitudinal Basal Forebrain Degeneration Interacts with TREM2\/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease. J Neurosci 40(9):1931\u20131942. https:\/\/doi.org\/10.1523\/jneurosci.1184-19.2019","journal-title":"J Neurosci"},{"issue":"3","key":"2348_CR103","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3233\/JAD-170136","volume":"58","author":"WM Snow","year":"2017","unstructured":"Snow WM, Dale R, O'Brien-Moran Z, Buist R, Peirson D, Martin M, Albensi BC (2017) In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging. J Alzheimers Dis 58(3):841\u2013853. https:\/\/doi.org\/10.3233\/JAD-170136","journal-title":"J Alzheimers Dis"},{"key":"2348_CR104","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.brainresbull.2020.01.003","volume":"156","author":"L Liu","year":"2020","unstructured":"Liu L, Liu Y, Li N, Huang R, Zheng X, Huang L, Hou S, Yuan Q (2020) Multiple inflammatory profiles of microglia and altered neuroimages in APP\/PS1 transgenic AD mice. Brain Res Bull 156:86\u2013104. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.01.003","journal-title":"Brain Res Bull"},{"key":"2348_CR105","doi-asserted-by":"publisher","unstructured":"Taquet M, Jankovski A, Rensonnet G, Jacobs D, des Rieux A, Macq B, Warfield SK, Scherrer B (2019) Extra-axonal restricted diffusion as an in-vivo marker of reactive microglia. Sci Rep 9 (1):13874. https:\/\/doi.org\/10.1038\/s41598-019-50432-5","DOI":"10.1038\/s41598-019-50432-5"},{"issue":"1","key":"2348_CR106","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-020-01878-2","volume":"17","author":"J Yang","year":"2020","unstructured":"Yang J, Fu Z, Zhang X, Xiong M, Meng L, Zhang Z (2020) TREM2 ectodomain and its soluble form in Alzheimer's disease. J Neuroinflammation 17(1):204. https:\/\/doi.org\/10.1186\/s12974-020-01878-2","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2348_CR107","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-020-00374-8","volume":"15","author":"LZ Ma","year":"2020","unstructured":"Ma LZ, Tan L, Bi YL, Shen XN, Xu W, Ma YH, Li HQ, Dong Q et al (2020) Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study. Mol Neurodegener 15(1):25. https:\/\/doi.org\/10.1186\/s13024-020-00374-8","journal-title":"Mol Neurodegener"},{"issue":"369","key":"2348_CR108","doi-asserted-by":"publisher","first-page":"369ra178","DOI":"10.1126\/scitranslmed.aag1767","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet M, Araque Caballero M, Kleinberger G, Bateman RJ, Fagan AM, Morris JC, Levin J, Danek A et al (2016) Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury. Sci Transl Med 8(369):369ra178. https:\/\/doi.org\/10.1126\/scitranslmed.aag1767","journal-title":"Sci Transl Med"},{"issue":"3","key":"2348_CR109","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","volume":"214","author":"L Zhong","year":"2017","unstructured":"Zhong L, Chen XF, Wang T, Wang Z, Liao C, Wang Z, Huang R, Wang D et al (2017) Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med 214(3):597\u2013607. https:\/\/doi.org\/10.1084\/jem.20160844","journal-title":"J Exp Med"},{"issue":"1","key":"2348_CR110","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12974-018-1310-6","volume":"15","author":"SM Bemiller","year":"2018","unstructured":"Bemiller SM, Maphis NM, Formica SV, Wilson GN, Miller CM, Xu G, Kokiko-Cochran ON, Kim KW et al (2018) Genetically enhancing the expression of chemokine domain of CX(3)CL1 fails to prevent tau pathology in mouse models of tauopathy. J Neuroinflammation 15(1):278. https:\/\/doi.org\/10.1186\/s12974-018-1310-6","journal-title":"J Neuroinflammation"},{"issue":"10","key":"2348_CR111","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.neurobiolaging.2014.03.026","volume":"35","author":"CE Hanzel","year":"2014","unstructured":"Hanzel CE, Pichet-Binette A, Pimentel LS, Iulita MF, Allard S, Ducatenzeiler A, Do Carmo S, Cuello AC (2014) Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease. Neurobiol Aging 35(10):2249\u20132262. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.03.026","journal-title":"Neurobiol Aging"},{"issue":"2","key":"2348_CR112","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11481-018-9822-5","volume":"14","author":"DJ Finneran","year":"2019","unstructured":"Finneran DJ, Morgan D, Gordon MN, Nash KR (2019) CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model. J Neuroimmune Pharmacol 14(2):312\u2013325. https:\/\/doi.org\/10.1007\/s11481-018-9822-5","journal-title":"J Neuroimmune Pharmacol"},{"issue":"7","key":"2348_CR113","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00702-015-1369-5","volume":"122","author":"S Strobel","year":"2015","unstructured":"Strobel S, Gr\u00fcnblatt E, Riederer P, Heinsen H, Arzberger T, Al-Sarraj S, Troakes C, Ferrer I et al (2015) Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPAR\u03b3. J Neural Transm (Vienna) 122(7):1069\u20131076. https:\/\/doi.org\/10.1007\/s00702-015-1369-5","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"2348_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-018-1861-8","volume":"136","author":"DH Paushter","year":"2018","unstructured":"Paushter DH, Du H, Feng T, Hu F (2018) The lysosomal function of progranulin, a guardian against neurodegeneration. Acta Neuropathol 136(1):1\u201317. https:\/\/doi.org\/10.1007\/s00401-018-1861-8","journal-title":"Acta Neuropathol"},{"issue":"11","key":"2348_CR115","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.celrep.2017.08.056","volume":"20","author":"BM Evers","year":"2017","unstructured":"Evers BM, Rodriguez-Navas C, Tesla RJ, Prange-Kiel J, Wasser CR, Yoo KS, McDonald J, Cenik B et al (2017) Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency. Cell Rep 20(11):2565\u20132574. https:\/\/doi.org\/10.1016\/j.celrep.2017.08.056","journal-title":"Cell Rep"},{"issue":"2","key":"2348_CR116","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s12035-016-9698-4","volume":"54","author":"HM Xu","year":"2017","unstructured":"Xu HM, Tan L, Wan Y, Tan MS, Zhang W, Zheng ZJ, Kong LL, Wang ZX et al (2017) PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis. Mol Neurobiol 54(2):1187\u20131195. https:\/\/doi.org\/10.1007\/s12035-016-9698-4","journal-title":"Mol Neurobiol"},{"issue":"21","key":"2348_CR117","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1212\/wnl.0000000000000445","volume":"82","author":"AM Nicholson","year":"2014","unstructured":"Nicholson AM, Finch NA, Thomas CS, Wojtas A, Rutherford NJ, Mielke MM, Roberts RO, Boeve BF et al (2014) Progranulin protein levels are differently regulated in plasma and CSF. Neurology 82(21):1871\u20131878. https:\/\/doi.org\/10.1212\/wnl.0000000000000445","journal-title":"Neurology"},{"key":"2348_CR118","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fncel.2020.00260","volume":"14","author":"Z Guan","year":"2020","unstructured":"Guan Z, Chen Z, Fu S, Dai L, Shen Y (2020) Progranulin Administration Attenuates \u03b2-Amyloid Deposition in the Hippocampus of 5xFAD Mice Through Modulating BACE1 Expression and Microglial Phagocytosis. Front Cell Neurosci 14:260. https:\/\/doi.org\/10.3389\/fncel.2020.00260","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"2348_CR119","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00401-017-1668-z","volume":"133","author":"H Takahashi","year":"2017","unstructured":"Takahashi H, Klein ZA, Bhagat SM, Kaufman AC, Kostylev MA, Ikezu T, Strittmatter SM (2017) Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network. Acta Neuropathol 133(5):785\u2013807. https:\/\/doi.org\/10.1007\/s00401-017-1668-z","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2348_CR120","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3233\/jad-150746","volume":"50","author":"E Morenas-Rodr\u00edguez","year":"2016","unstructured":"Morenas-Rodr\u00edguez E, Cervera-Carles L, Vilaplana E, Alcolea D, Carmona-Iragui M, Dols-Icardo O, Ribosa-Nogu\u00e9 R, Mu\u00f1oz-Llahuna L et al (2016) Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias. J Alzheimers Dis 50(2):539\u2013546. https:\/\/doi.org\/10.3233\/jad-150746","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"2348_CR121","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/s1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T et al (2015) Neuroinflammation in Alzheimer's disease. Lancet Neurol 14(4):388\u2013405. https:\/\/doi.org\/10.1016\/s1474-4422(15)70016-5","journal-title":"Lancet Neurol"},{"issue":"1","key":"2348_CR122","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/jad-170602","volume":"62","author":"BM Bettcher","year":"2018","unstructured":"Bettcher BM, Johnson SC, Fitch R, Casaletto KB, Heffernan KS, Asthana S, Zetterberg H, Blennow K et al (2018) Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage. J Alzheimers Dis 62(1):385\u2013397. https:\/\/doi.org\/10.3233\/jad-170602","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"2348_CR123","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1007\/s12035-017-0707-z","volume":"55","author":"KM Budge","year":"2018","unstructured":"Budge KM, Neal ML, Richardson JR, Safadi FF (2018) Glycoprotein NMB: an Emerging Role in Neurodegenerative Disease. Mol Neurobiol 55(6):5167\u20135176. https:\/\/doi.org\/10.1007\/s12035-017-0707-z","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2348_CR124","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/brb3.39","volume":"2","author":"JJ Huang","year":"2012","unstructured":"Huang JJ, Ma WJ, Yokoyama S (2012) Expression and immunolocalization of Gpnmb, a glioma-associated glycoprotein, in normal and inflamed central nervous systems of adult rats. Brain Behav 2(2):85\u201396. https:\/\/doi.org\/10.1002\/brb3.39","journal-title":"Brain Behav"},{"issue":"11","key":"2348_CR125","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1002\/glia.23034","volume":"64","author":"K Kawahara","year":"2016","unstructured":"Kawahara K, Hirata H, Ohbuchi K, Nishi K, Maeda A, Kuniyasu A, Yamada D, Maeda T et al (2016) The novel monoclonal antibody 9F5 reveals expression of a fragment of GPNMB\/osteoactivin processed by furin-like protease(s) in a subpopulation of microglia in neonatal rat brain. Glia 64(11):1938\u20131961. https:\/\/doi.org\/10.1002\/glia.23034","journal-title":"Glia"},{"issue":"4","key":"2348_CR126","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, Mancuso R, Chen WT et al (2019) The Major Risk Factors for Alzheimer's Disease: Age, Sex, and Genes Modulate the Microglia Response to A\u03b2 Plaques. Cell Rep 27(4):1293\u20131306.e1296. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.099","journal-title":"Cell Rep"},{"issue":"2","key":"2348_CR127","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5582\/irdr.2019.01049","volume":"8","author":"JI Satoh","year":"2019","unstructured":"Satoh JI, Kino Y, Yanaizu M, Ishida T, Saito Y (2019) Microglia express GPNMB in the brains of Alzheimer's disease and Nasu-Hakola disease. Intractable Rare Dis Res 8(2):120\u2013128. https:\/\/doi.org\/10.5582\/irdr.2019.01049","journal-title":"Intractable Rare Dis Res"},{"issue":"1","key":"2348_CR128","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","volume":"13","author":"SE O'Bryant","year":"2017","unstructured":"O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, Posner H et al (2017) Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement 13(1):45\u201358. https:\/\/doi.org\/10.1016\/j.jalz.2016.09.014","journal-title":"Alzheimers Dement"},{"issue":"4","key":"2348_CR129","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s12276-020-0418-9","volume":"52","author":"SA Park","year":"2020","unstructured":"Park SA, Han SM, Kim CE (2020) New fluid biomarkers tracking non-amyloid-\u03b2 and non-tau pathology in Alzheimer's disease. Exp Mol Med 52(4):556\u2013568. https:\/\/doi.org\/10.1038\/s12276-020-0418-9","journal-title":"Exp Mol Med"},{"issue":"1-2","key":"2348_CR130","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jns.2010.10.009","volume":"300","author":"GY Hsiung","year":"2011","unstructured":"Hsiung GY, Fok A, Feldman HH, Rademakers R, Mackenzie IR (2011) rs5848 polymorphism and serum progranulin level. J Neurol Sci 300(1-2):28\u201332. https:\/\/doi.org\/10.1016\/j.jns.2010.10.009","journal-title":"J Neurol Sci"},{"issue":"1-2","key":"2348_CR131","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jns.2009.07.011","volume":"287","author":"M Carecchio","year":"2009","unstructured":"Carecchio M, Fenoglio C, De Riz M, Guidi I, Comi C, Cortini F, Venturelli E, Restelli I et al (2009) Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease. J Neurol Sci 287(1-2):291\u2013293. https:\/\/doi.org\/10.1016\/j.jns.2009.07.011","journal-title":"J Neurol Sci"},{"issue":"2","key":"2348_CR132","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/jad-121606","volume":"35","author":"P Piscopo","year":"2013","unstructured":"Piscopo P, Rivabene R, Galimberti D, Crestini A, Talarico G, Vanacore N, Scarpini E, Bruno G et al (2013) Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study. J Alzheimers Dis 35(2):313\u2013318. https:\/\/doi.org\/10.3233\/jad-121606","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2348_CR133","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3233\/jad-2012-112120","volume":"31","author":"A Antonell","year":"2012","unstructured":"Antonell A, Gil S, S\u00e1nchez-Valle R, Balasa M, Bosch B, Prat MC, Chiollaz AC, Fern\u00e1ndez M et al (2012) Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort. J Alzheimers Dis 31(3):581\u2013591. https:\/\/doi.org\/10.3233\/jad-2012-112120","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"2348_CR134","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/acn3.560","volume":"5","author":"YA Cooper","year":"2018","unstructured":"Cooper YA, Nachun D, Dokuru D, Yang Z, Karydas AM, Serrero G, Yue B, Boxer AL et al (2018) Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment. Ann Clin Transl Neurol 5(5):616\u2013629. https:\/\/doi.org\/10.1002\/acn3.560","journal-title":"Ann Clin Transl Neurol"},{"key":"2348_CR135","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.pharmthera.2018.03.002","volume":"188","author":"B Shafit-Zagardo","year":"2018","unstructured":"Shafit-Zagardo B, Gruber RC, DuBois JC (2018) The role of TAM family receptors and ligands in the nervous system: From development to pathobiology. Pharmacol Ther 188:97\u2013117. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.03.002","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2348_CR136","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/1673-5374.264444","volume":"15","author":"H Nakanishi","year":"2020","unstructured":"Nakanishi H (2020) Microglial cathepsin B as a key driver of inflammatory brain diseases and brain aging. Neural Regen Res 15(1):25\u201329. https:\/\/doi.org\/10.4103\/1673-5374.264444","journal-title":"Neural Regen Res"},{"issue":"1","key":"2348_CR137","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13195-019-0533-9","volume":"11","author":"S Sj\u00f6din","year":"2019","unstructured":"Sj\u00f6din S, Brinkmalm G, \u00d6hrfelt A, Parnetti L, Paciotti S, Hansson O, Hardy J, Blennow K et al (2019) Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease. Alzheimers Res Ther 11(1):82. https:\/\/doi.org\/10.1186\/s13195-019-0533-9","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"2348_CR138","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.yexcr.2017.11.015","volume":"362","author":"H Bai","year":"2018","unstructured":"Bai H, Yang B, Yu W, Xiao Y, Yu D, Zhang Q (2018) Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome. Exp Cell Res 362(1):180\u2013187. https:\/\/doi.org\/10.1016\/j.yexcr.2017.11.015","journal-title":"Exp Cell Res"},{"issue":"2","key":"2348_CR139","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3233\/jad-190682","volume":"73","author":"P Yin","year":"2020","unstructured":"Yin P, Wang S, Wei Y, Wang X, Zhang J, Yin X, Feng J, Zhu M (2020) Maresin1 Decreased Microglial Chemotaxis and Ameliorated Inflammation Induced by Amyloid-\u03b242 in Neuron-Microglia Co-Culture Models. J Alzheimers Dis 73(2):503\u2013515. https:\/\/doi.org\/10.3233\/jad-190682","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"2348_CR140","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1007\/s12035-015-9544-0","volume":"53","author":"M Zhu","year":"2016","unstructured":"Zhu M, Wang X, Hjorth E, Colas RA, Schroeder L, Granholm AC, Serhan CN, Schultzberg M (2016) Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase A\u03b242 Phagocytosis. Mol Neurobiol 53(4):2733\u20132749. https:\/\/doi.org\/10.1007\/s12035-015-9544-0","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2348_CR141","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/bpa.12763","volume":"30","author":"Y Gui","year":"2020","unstructured":"Gui Y, Marks JD, Das S, Hyman BT, Serrano-Pozo A (2020) Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains. Brain Pathol 30(1):151\u2013164. https:\/\/doi.org\/10.1111\/bpa.12763","journal-title":"Brain Pathol"},{"issue":"13","key":"2348_CR142","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1093\/hmg\/ddz045","volume":"28","author":"S Chiquita","year":"2019","unstructured":"Chiquita S, Ribeiro M, Castelhano J, Oliveira F, Sereno J, Batista M, Abrunhosa A, Rodrigues-Neves AC et al (2019) A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss. Hum Mol Genet 28(13):2174\u20132188. https:\/\/doi.org\/10.1093\/hmg\/ddz045","journal-title":"Hum Mol Genet"},{"issue":"1","key":"2348_CR143","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41467-018-08279-3","volume":"10","author":"D Felsky","year":"2019","unstructured":"Felsky D, Roostaei T, Nho K, Risacher SL, Bradshaw EM, Petyuk V, Schneider JA, Saykin A et al (2019) Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun 10(1):409. https:\/\/doi.org\/10.1038\/s41467-018-08279-3","journal-title":"Nat Commun"},{"issue":"3","key":"2348_CR144","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/0271678x16646788","volume":"37","author":"M Yokokura","year":"2017","unstructured":"Yokokura M, Terada T, Bunai T, Nakaizumi K, Takebayashi K, Iwata Y, Yoshikawa E, Futatsubashi M et al (2017) Depiction of microglial activation in aging and dementia: Positron emission tomography with [(11)C]DPA713 versus [(11)C]( R)PK11195. J Cereb Blood Flow Metab 37(3):877\u2013889. https:\/\/doi.org\/10.1177\/0271678x16646788","journal-title":"J Cereb Blood Flow Metab"},{"key":"2348_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nucmedbio.2018.09.001","volume":"67","author":"T Keller","year":"2018","unstructured":"Keller T, L\u00f3pez-Pic\u00f3n FR, Krzyczmonik A, Forsback S, Kirjavainen AK, Takkinen JS, Alzghool O, Rajander J et al (2018) [(18)F]F-DPA for the detection of activated microglia in a mouse model of Alzheimer's disease. Nucl Med Biol 67:1\u20139. https:\/\/doi.org\/10.1016\/j.nucmedbio.2018.09.001","journal-title":"Nucl Med Biol"},{"issue":"12","key":"2348_CR146","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.2967\/jnumed.116.187625","volume":"58","author":"S Deleye","year":"2017","unstructured":"Deleye S, Waldron AM, Verhaeghe J, Bottelbergs A, Wyffels L, Van Broeck B, Langlois X, Schmidt M et al (2017) Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease. J Nucl Med 58(12):1977\u20131983. https:\/\/doi.org\/10.2967\/jnumed.116.187625","journal-title":"J Nucl Med"},{"issue":"3","key":"2348_CR147","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2967\/jnumed.117.197608","volume":"59","author":"FR L\u00f3pez-Pic\u00f3n","year":"2018","unstructured":"L\u00f3pez-Pic\u00f3n FR, Snellman A, Eskola O, Helin S, Solin O, Haaparanta-Solin M, Rinne JO (2018) Neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease. J Nucl Med 59(3):509\u2013515. https:\/\/doi.org\/10.2967\/jnumed.117.197608","journal-title":"J Nucl Med"},{"issue":"4","key":"2348_CR148","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2967\/jnumed.118.217703","volume":"60","author":"C Focke","year":"2019","unstructured":"Focke C, Blume T, Zott B, Shi Y, Deussing M, Peters F, Schmidt C, Kleinberger G et al (2019) Early and Longitudinal Microglial Activation but Not Amyloid Accumulation Predicts Cognitive Outcome in PS2APP Mice. J Nucl Med 60(4):548\u2013554. https:\/\/doi.org\/10.2967\/jnumed.118.217703","journal-title":"J Nucl Med"},{"issue":"1","key":"2348_CR149","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12974-018-1174-9","volume":"15","author":"A L\u00f3pez","year":"2018","unstructured":"L\u00f3pez A, Aparicio N, Pazos MR, Grande MT, Barreda-Manso MA, Benito-Cuesta I, V\u00e1zquez C, Amores M et al (2018) Cannabinoid CB(2) receptors in the mouse brain: relevance for Alzheimer's disease. J Neuroinflammation 15(1):158. https:\/\/doi.org\/10.1186\/s12974-018-1174-9","journal-title":"J Neuroinflammation"},{"key":"2348_CR150","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbi.2017.08.015","volume":"67","author":"G Navarro","year":"2018","unstructured":"Navarro G, Borroto-Escuela D, Angelats E, Etayo \u00cd, Reyes-Resina I, Pulido-Salgado M, Rodr\u00edguez-P\u00e9rez AI, Canela EI et al (2018) Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB(1) and CB(2) receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia. Brain Behav Immun 67:139\u2013151. https:\/\/doi.org\/10.1016\/j.bbi.2017.08.015","journal-title":"Brain Behav Immun"},{"key":"2348_CR151","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejphar.2017.05.044","volume":"811","author":"J Wu","year":"2017","unstructured":"Wu J, Hocevar M, Foss JF, Bie B, Naguib M (2017) Activation of CB(2) receptor system restores cognitive capacity and hippocampal Sox2 expression in a transgenic mouse model of Alzheimer's disease. Eur J Pharmacol 811:12\u201320. https:\/\/doi.org\/10.1016\/j.ejphar.2017.05.044","journal-title":"Eur J Pharmacol"},{"key":"2348_CR152","doi-asserted-by":"publisher","first-page":"134286","DOI":"10.1016\/j.neulet.2019.134286","volume":"707","author":"C Li","year":"2019","unstructured":"Li C, Shi J, Wang B, Li J, Jia H (2019) CB2 cannabinoid receptor agonist ameliorates novel object recognition but not spatial memory in transgenic APP\/PS1 mice. Neurosci Lett 707:134286. https:\/\/doi.org\/10.1016\/j.neulet.2019.134286","journal-title":"Neurosci Lett"},{"key":"2348_CR153","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.lfs.2018.12.059","volume":"219","author":"VR Askari","year":"2019","unstructured":"Askari VR, Shafiee-Nick R (2019) The protective effects of \u03b2-caryophyllene on LPS-induced primary microglia M(1)\/M(2) imbalance: A mechanistic evaluation. Life Sci 219:40\u201373. https:\/\/doi.org\/10.1016\/j.lfs.2018.12.059","journal-title":"Life Sci"},{"issue":"36","key":"2348_CR154","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O'Keeffe S, Phatnani HP, Guarnieri P et al (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34(36):11929\u201311947. https:\/\/doi.org\/10.1523\/JNEUROSCI.1860-14.2014","journal-title":"J Neurosci"},{"key":"2348_CR155","doi-asserted-by":"publisher","first-page":"104956","DOI":"10.1016\/j.nbd.2020.104956","volume":"142","author":"BT Casali","year":"2020","unstructured":"Casali BT, MacPherson KP, Reed-Geaghan EG, Landreth GE (2020) Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies. Neurobiol Dis 142:104956. https:\/\/doi.org\/10.1016\/j.nbd.2020.104956","journal-title":"Neurobiol Dis"},{"issue":"7","key":"2348_CR156","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K et al (2017) A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease. Cell 169(7):1276\u20131290 e1217. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018","journal-title":"Cell"},{"issue":"19","key":"2348_CR157","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.7150\/thno.25572","volume":"8","author":"A Villa","year":"2018","unstructured":"Villa A, Klein B, Janssen B, Pedragosa J, Pepe G, Zinnhardt B, Vugts DJ, Gelosa P et al (2018) Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state. Theranostics 8(19):5400\u20135418. https:\/\/doi.org\/10.7150\/thno.25572","journal-title":"Theranostics"},{"issue":"12","key":"2348_CR158","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1021\/acschemneuro.8b00334","volume":"9","author":"DM Angelova","year":"2018","unstructured":"Angelova DM, Brown DR (2018) Altered Processing of \u03b2-Amyloid in SH-SY5Y Cells Induced by Model Senescent Microglia. ACS Chem Neurosci 9(12):3137\u20133152. https:\/\/doi.org\/10.1021\/acschemneuro.8b00334","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"2348_CR159","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/bpa.12704","volume":"29","author":"A McIntosh","year":"2019","unstructured":"McIntosh A, Mela V, Harty C, Minogue AM, Costello DA, Kerskens C, Lynch MA (2019) Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP\/PS1 mice. Brain Pathol 29(5):606\u2013621. https:\/\/doi.org\/10.1111\/bpa.12704","journal-title":"Brain Pathol"},{"key":"2348_CR160","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbi.2019.02.011","volume":"79","author":"TM Lancaster","year":"2019","unstructured":"Lancaster TM, Hill MJ, Sims R, Williams J (2019) Microglia - mediated immunity partly contributes to the genetic association between Alzheimer's disease and hippocampal volume. Brain Behav Immun 79:267\u2013273. https:\/\/doi.org\/10.1016\/j.bbi.2019.02.011","journal-title":"Brain Behav Immun"},{"issue":"8","key":"2348_CR161","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1084\/jem.194.8.1111","volume":"194","author":"A Bouchon","year":"2001","unstructured":"Bouchon A, Hern\u00e1ndez-Munain C, Cella M, Colonna M (2001) A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med 194(8):1111\u20131122. https:\/\/doi.org\/10.1084\/jem.194.8.1111","journal-title":"J Exp Med"},{"issue":"2","key":"2348_CR162","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/mp.2017.246","volume":"23","author":"KE Hopperton","year":"2018","unstructured":"Hopperton KE, Mohammad D, Tr\u00e9panier MO, Giuliano V, Bazinet RP (2018) Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review. Mol Psychiatry 23(2):177\u2013198. https:\/\/doi.org\/10.1038\/mp.2017.246","journal-title":"Mol Psychiatry"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02348-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02348-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02348-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T10:49:23Z","timestamp":1625482163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02348-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":162,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2348"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02348-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"29 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have given final approval of the version and agreed with the publication of this study here.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}